CARGO Therapeutics, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2025.

Location
San Carlos, CA
Fiscal year end
31 December
Latest financial report
06 Aug 2025

Quick Takeaways

  • CARGO Therapeutics, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q2 2025.
  • Headline metric: Return On Equity -66%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-20%</span>.
  • Most recent SEC facts end date: 01 Aug 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-08-01) highlights Return On Equity -65.8%, Return On Assets -59.2%, and Current Ratio 12.37x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

21.0/100

Weak Confidence medium

Return On Equity

-66%

Metric score 0.0/100

Return On Assets

-59%

Metric score 0.0/100

Financial Health

Current Ratio
12.37x
Debt to Equity
0.16x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-66%

YoY: -20%

Industry median: -47% (n=218)

View history

Return On Assets

-59%

YoY: +97%

Industry median: -44% (n=217)

View history

Current Ratio

12.37x

YoY: -27%

Industry median: 3.67x (n=218)

View history

Debt-to-equity

0.16x

YoY: -8.4%

Industry median: 0.31x (n=169)

View history

NetIncomeLoss YoY

-50%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity -66% -20%
Return On Assets -59% +97%

Financial Health

Metric Latest value YoY change
Current Ratio 12.37x -27%
Debt-to-equity 0.16x -8.4%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -50%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 48,364,311 +5.4%
Common Stock, Value, Issued $46,000 0%
Weighted Average Number of Shares Outstanding, Basic 48,133,609 +11%
Weighted Average Number of Shares Outstanding, Diluted 48,133,609 +11%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $113,582,000 -3.1%
General and Administrative Expense $41,610,000 +14%
Operating Income (Loss) $238,570,000 -55%
Earnings Per Share, Basic -4 -116%
Earnings Per Share, Diluted -4 -116%
Cash and Cash Equivalents, at Carrying Value $107,746,000 -30%
Marketable Securities, Current $144,821,000 -50%
Assets, Current $258,605,000 -42%
Assets $258,605,000 -47%
Accounts Payable, Current $8,668,000 +24%
Employee-related Liabilities, Current $25,000 -99%
Accrued Liabilities, Current $739,000 -87%
Liabilities, Current $20,908,000 -21%
Operating Lease, Liability, Noncurrent $0 -100%
Liabilities $20,908,000 -61%
Accumulated Other Comprehensive Income (Loss), Net of Tax $9,000 +97%
Retained Earnings (Accumulated Deficit) $447,083,000 -98%
Stockholders' Equity Attributable to Parent $237,697,000 -45%
Liabilities and Equity $258,605,000 -47%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $108,313,000 -30%
Operating Lease, Liability $578,000 -98%
Depreciation $2,216,000 +4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $221,464,000 -50%
Lessee, Operating Lease, Liability, to be Paid $584,000 -99%
Operating Lease, Liability, Current $578,000 -11%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 -7.3%
Additional Paid in Capital $684,743,000 +3.5%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY